Summary:

In this issue, Malone and colleagues identified the nuclear mRNA export factor NXT1 as a novel genetic dependency in neuroblastoma as well as several additional pediatric cancers. These data highlight potential cell type–specific differences in the nuclear export machinery that may be exploited as cancer therapeutics.

See related article by Malone et al., p. 2282.

You do not currently have access to this content.